Skip to main content

Some NLM-NCBI services and products are experiencing heavy traffic, which may affect performance and availability. We apologize for the inconvenience and appreciate your patience. For assistance, please contact our Help Desk at info@ncbi.nlm.nih.gov.

JAMA Network logoLink to JAMA Network
. 2022 Jan 14;5(1):e2147432. doi: 10.1001/jamanetworkopen.2021.47432

Errors in Figure 3

PMCID: PMC8760610  PMID: 35029668

In the Original Investigation titled “Cost-effectiveness of Cardiac Telerehabilitation With Relapse Prevention for the Treatment of Patients With Coronary Artery Disease in the Netherlands,”1 published December 2, 2021, the dashed horizontal black line and colored data curves in Figure 3B were positioned incorrectly. That line and the curves should have been slightly higher in the graph, with the dashed line even with 0.5% on the y-axis and the colored data curves proportionately higher as well. This article has been corrected.1

Reference

  • 1.Brouwers RWM, van der Poort EKJ, Kemps HMC, van den Akker-van Marle ME, Kraal JJ. Cost-effectiveness of cardiac telerehabilitation with relapse prevention for the treatment of patients with coronary artery disease in the Netherlands. JAMA Netw Open. 2021;4(12):e2136652. doi: 10.1001/jamanetworkopen.2021.36652 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from JAMA Network Open are provided here courtesy of American Medical Association

RESOURCES